Unsal Y, Gozmen O, User I, Hizarcioglu H, Gulhan B, Ekinci S
Front Endocrinol (Lausanne). 2023; 14:1209189.
PMID: 37560302
PMC: 10407558.
DOI: 10.3389/fendo.2023.1209189.
Mitini-Nkhoma S, Chimbayo E, Mzinza D, Mhango D, Chirambo A, Mandalasi C
Front Immunol. 2021; 12():665785.
PMID: 34248944
PMC: 8264357.
DOI: 10.3389/fimmu.2021.665785.
Amory J, Hong S, Yu X, Muller C, Faustman E, Goldstein A
Theriogenology. 2014; 82(1):152-9.
PMID: 24746827
PMC: 4079550.
DOI: 10.1016/j.theriogenology.2014.03.014.
Ramanathan R, Talaat K, Fedorko D, Mahanty S, Nash T
Am J Trop Med Hyg. 2011; 84(1):109-17.
PMID: 21212212
PMC: 3005496.
DOI: 10.4269/ajtmh.2011.10-0437.
Davis R, Balfour J
Pharmacoeconomics. 1995; 8(3):253-69.
PMID: 10155621
DOI: 10.2165/00019053-199508030-00008.
Candida endophthalmitis in a heroin addict: a case report.
Salmon J, PARTRIDGE B, Spalton D
Br J Ophthalmol. 1983; 67(5):306-9.
PMID: 6601492
PMC: 1040048.
DOI: 10.1136/bjo.67.5.306.
Drug effects on the liver. An updated tabular compilation of drugs and drug-related hepatic diseases.
Ludwig J, Axelsen R
Dig Dis Sci. 1983; 28(7):651-66.
PMID: 6305608
DOI: 10.1007/BF01299927.
Severe hepatitis during ketoconazole therapy.
Okumura H, Aramaki T, Satomura K, Iizuka K, Ohta M, Katsuta Y
Gastroenterol Jpn. 1983; 18(2):142-7.
PMID: 6303886
DOI: 10.1007/BF02774689.
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Graybill J, Craven P
Drugs. 1983; 25(1):41-62.
PMID: 6297871
DOI: 10.2165/00003495-198325010-00003.
Ketoconazole.
Hay R
Br Med J (Clin Res Ed). 1982; 285(6342):584-5.
PMID: 6297655
PMC: 1499408.
DOI: 10.1136/bmj.285.6342.584.
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.
Heel R, Brogden R, Carmine A, Morley P, Speight T, Avery G
Drugs. 1982; 23(1-2):1-36.
PMID: 6276122
DOI: 10.2165/00003495-198223010-00001.
The effect of ketoconazole on experimental paracoccidioidomycosis in the Syrian hamster: immunological and histopathological study.
Mota N, Viero R, Peracoli M, Soares A, MONTENEGRO M
Mycopathologia. 1984; 88(2-3):141-8.
PMID: 6098832
DOI: 10.1007/BF00436445.
Antifungal therapy of dermatophytosis in guinea pigs and congenitally athymic rats.
Weber J, Balish E
Mycopathologia. 1985; 90(1):47-54.
PMID: 4039795
DOI: 10.1007/BF00437276.
Ketoconazole-induced fulminant hepatitis.
Bercoff E, Bernuau J, Degott C, Kalis B, Lemaire A, Tilly H
Gut. 1985; 26(6):636-8.
PMID: 4007605
PMC: 1432772.
DOI: 10.1136/gut.26.6.636.
Ketoconazole: a reappraisal.
Hay R
Br Med J (Clin Res Ed). 1985; 290(6464):260-1.
PMID: 3917777
PMC: 1417545.
DOI: 10.1136/bmj.290.6464.260.
Ketoconazole impairs biliary excretory function in the isolated perfused rat liver.
Gaeta G, Tripodi M
Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(6):697-700.
PMID: 3627286
DOI: 10.1007/BF00166989.
Prolonged jaundice following ketoconazole-induced hepatic injury.
BENSON G, Anderson P, Combes B, Ishak K
Dig Dis Sci. 1988; 33(2):240-6.
PMID: 3338372
DOI: 10.1007/BF01535739.
Hepatic reactions associated with ketoconazole in the United Kingdom.
Lake-Bakaar G, Scheuer P, Sherlock S
Br Med J (Clin Res Ed). 1987; 294(6569):419-22.
PMID: 3101906
PMC: 1245420.
DOI: 10.1136/bmj.294.6569.419.
High-dose itraconazole in the treatment of severe mycoses.
Sharkey P, Rinaldi M, Dunn J, Hardin T, Fetchick R, Graybill J
Antimicrob Agents Chemother. 1991; 35(4):707-13.
PMID: 1648887
PMC: 245083.
DOI: 10.1128/AAC.35.4.707.
Adverse drug reactions to systemic antifungals. Prevention and management.
Perfect J, Lindsay M, Drew R
Drug Saf. 1992; 7(5):323-63.
PMID: 1418692
DOI: 10.2165/00002018-199207050-00003.
